EMX2OS and neoplasm: For the tumor stage, the results demonstrated that the expression of eRNA EMX2OS is higher in patients with Stage IV than those in Stage I. Also, the expression of eRNA EMX2OS is higher in patients with Stage II than in those with Stage I. The eRNA EMX2OS expression in patients with tumors is higher than those patients with tumor-free (Fig. 3).